North America & Europe Methylnaltrexone Market: By Dosage (Tablets, Solution, Injection); Route of Administration (Oral and Subcutaneous); End User (Pharmaceutical Companies, and Research Institutes); Type (API and Finished Product); Distribution Channel (Online and Offline); Region—Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2023–2031
North American and European methylnaltrexone market was valued at US$ 8.3 million in 2022 and is projected to surpass market valuation of US$ 12.7 million by 2031 at a CAGR of 4.9% during the forecast period 2023–2031. Read More
We Are Trusted By These Great Companies!
Published On: 09-Sep-2023 | Format: | Report ID: AA0923608